Mesoblast (MESO) Net Income towards Common Stockholders (2016 - 2023)
Historic Net Income towards Common Stockholders for Mesoblast (MESO) over the last 10 years, with Q4 2024 value amounting to -$47.9 million.
- Mesoblast's Net Income towards Common Stockholders fell 4731.25% to -$47.9 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$113.0 million, marking a year-over-year increase of 3209.15%. This contributed to the annual value of -$102.1 million for FY2025, which is 1612.85% down from last year.
- As of Q4 2024, Mesoblast's Net Income towards Common Stockholders stood at -$47.9 million, which was down 4731.25% from -$32.5 million recorded in Q2 2024.
- Mesoblast's Net Income towards Common Stockholders' 5-year high stood at $15.3 million during Q1 2020, with a 5-year trough of -$76.8 million in Q1 2021.
- Over the past 5 years, Mesoblast's median Net Income towards Common Stockholders value was -$32.5 million (recorded in 2023), while the average stood at -$36.4 million.
- In the last 5 years, Mesoblast's Net Income towards Common Stockholders crashed by 60285.66% in 2021 and then skyrocketed by 7225.57% in 2022.
- Over the past 5 years, Mesoblast's Net Income towards Common Stockholders (Quarter) stood at -$50.2 million in 2020, then surged by 48.04% to -$26.1 million in 2021, then tumbled by 58.48% to -$41.4 million in 2022, then increased by 21.35% to -$32.5 million in 2023, then crashed by 47.31% to -$47.9 million in 2024.
- Its Net Income towards Common Stockholders was -$47.9 million in Q4 2024, compared to -$32.5 million in Q2 2024 and -$32.5 million in Q4 2023.